Allergy & Immunology - European Medical Journal

Continue

Allergy & Immunology

Filter
10 Mins
20 Jul 2023

Editor’s Pick: Drug-Induced Thrombocytopenic Purpura

In the present systematic review and meta-analysis, the authors analysed case reports of drug-induced thrombocytopenia/drug-induced…
3 Mins
17 Jul 2023

The Role of Co-Factors in Mast Cell Activation

Degranulation of activated mast cells affects many conditions and can modulate physiological and pathological responses…
8 Mins
5 Jul 2023

Paediatric Post-SARS-CoV-2 Multisystemic Syndrome

A novel characterised hyper inflammatory condition has been observed in children who have recently had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections during the COVID-19 pandemic.
3 Mins
29 Jun 2023

The Danger of Disappearing Allergen Skin Test Substances

Allergic diseases affect approximately one-quarter to one-half of the average population under 50 years of age in Central Europe…
11 Mins
12 Apr 2023

IL-17 and -23 Inhibitors for the Treatment of Psoriasis

Psoriasis is a chronic inflammatory skin disorder affecting approximately 60 million people worldwide. The condition presents with rapid hyperproliferation and dysregulated differentiation of epidermal keratinocytes, manifesting clinically as salmon pink plaques with overlying silvery-white scale.
3 Mins
21 Mar 2023

Interview: David Stukus

David Stukus – Professor of Clinical Pediatrics, Division of Allergy and Immunology; Director, Food Allergy Treatment Center, Nationwide Children’s Hospital and The Ohio State University College of Medicine, Columbus, Ohio, USA
10 Mins
19 Jan 2023

Can Human Milk Oligosaccharides Modulate the Allergic Response and Improve the Management of Cow’s Milk Protein Allergy?

Human milk oligosaccharides (HMOs) support the development of the infant microbiome and have immune benefits in the management of cow’s milk protein allergy (CMPA).
10 Mins
18 Aug 2022

The Cow's Milk-Related Symptom Score (CoMiSSTM) to Facilitate the Awareness of Cow's Milk Allergy

CoMiSSTM is a clinical tool developed to increase awareness among healthcare professionals (HCP) of possible symptoms of cow’s milk allergy (CMA) in infants. During this symposium, leading experts in the field of paediatric gastroenterology, allergy, and nutrition highlighted how CoMiSS can facilitate awareness of CMA and support HCPs in improving the patient journey from symptom presentation to diagnosis.